- List
- By Topic
- On Map
- Search Details

"Ocular melanoma"
Need help? See RSS Feeds
Choose a feed type:

"Ocular melanoma" (44 records)
Need help? See Downloading Content for Analysis
For Advanced Users: Full Study Record XML Download
1 | NCT00168870 | Unknown † | Study of Metastatic Ocular Melanoma |
|
|
Interventional | Phase 2 |
|
Other |
|
|
48 | All | 18 Years and older (Adult, Senior) | NCT00168870 | Haema CBF AHM UK/AS 04 | February 2003 | September 15, 2005 | August 31, 2007 |
|
||||
2 | NCT01893099 | Active, not recruiting | Sorafenib and Radioembolization With Sir-Spheres® for the Treatment of Metastatic Ocular Melanoma |
|
|
Interventional | Phase 1 |
|
Other |
|
|
24 | All | 18 Years and older (Adult, Senior) | NCT01893099 | CHUV-CePO-code 16295 | June 2013 | December 2017 | December 2017 | July 8, 2013 | August 23, 2017 |
|
||
3 | NCT01200238 | Active, not recruiting | STA-9090(Ganetespib) in Metastatic Ocular Melanoma |
|
|
Interventional | Phase 2 |
|
Other / Industry |
|
|
30 | All | 18 Years and older (Adult, Senior) | NCT01200238 | 10-137 | June 2010 | May 14, 2016 | June 2019 | September 13, 2010 | February 1, 2018 |
|
||
4 | NCT00621439 | Withdrawn | Investigative Trial of Interferon Alpha-2b To Shrink Cancer of the Eye |
|
|
Interventional | Not Applicable |
|
Other |
|
|
0 | All | 18 Years and older (Adult, Senior) | NCT00621439 | IRB00002566 | March 2007 | June 2008 | February 22, 2008 | December 2, 2013 | ||||
5 | NCT01814046 | Completed Has Results |
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Ocular Melanoma |
|
|
Interventional | Phase 2 |
|
NIH |
|
|
24 | All | 16 Years to 75 Years (Child, Adult, Senior) | NCT01814046 | 130093 13-C-0093 |
March 1, 2013 | May 1, 2017 | May 31, 2017 | March 19, 2013 | January 23, 2018 | July 24, 2017 |
|
|
6 | NCT01930968 | Not yet recruiting | Definity for Ultrasound of Intraocular Tumors |
|
Observational |
|
Other |
|
|
10 | All | 20 Years and older (Adult, Senior) | NCT01930968 | IRB00039493 | January 2019 | December 2019 | December 2019 | August 29, 2013 | February 28, 2018 |
|
||||
7 | NCT01355120 | Completed | THE IPI - Trial in Advanced Melanoma: Melanoma Patients With Advanced Disease |
|
|
Interventional | Phase 2 |
|
Other |
|
|
171 | All | 18 Years and older (Adult, Senior) | NCT01355120 | DeCOG -MM-PAL11 | DeCOG | October 2011 | September 2012 | September 2013 | May 17, 2011 | June 23, 2014 |
|
|
8 | NCT00346372 | Recruiting | Optical Coherence Tomography of Retinal Abnormalities Associated With Choroidal Nevus, Choroidal Melanoma and Choroidal Melanoma Treated With Iodine-125 Brachytherapy |
|
Observational |
|
Other |
|
800 | All | 18 Years and older (Adult, Senior) | NCT00346372 | UCLA IRB#03-11-052 | March 2004 | December 2019 | January 2021 | June 29, 2006 | January 4, 2018 |
|
|||||
9 | NCT03172299 | Not yet recruiting | Prevention of Neovascular Glaucoma by Intravitreal Injections of Anti-VEGF in Patients Treated With Proton Therapy for a Large Choroidal Melanoma |
|
|
Interventional | Phase 3 |
|
Other |
|
|
56 | All | 18 Years and older (Adult, Senior) | NCT03172299 | 15-API-01 | PROTECT | June 2017 | June 2024 | December 2024 | June 1, 2017 | June 7, 2017 |
|
|
10 | NCT02909517 | Recruiting | The Role of Inflammation in Ocular Tumours |
|
|
Observational |
|
Other |
|
|
30 | All | 18 Years and older (Adult, Senior) | NCT02909517 | 14-416 | March 2016 | February 2017 | September 21, 2016 | September 21, 2016 |
|
||||
11 | NCT00344799 | Recruiting | Cytogenetic Study of Ocular Melanoma |
|
Observational |
|
Other |
|
200 | All | 18 Years and older (Adult, Senior) | NCT00344799 | UCLA IRB#04-12-084 | January 8, 2005 | August 31, 2020 | August 31, 2021 | June 27, 2006 | September 13, 2017 |
|
|||||
12 | NCT00351728 | Completed | Combined PET/CT Imaging for the Early Detection of Ocular Melanoma Metastasis Compared to CT Scanning Alone |
|
Observational |
|
Other |
|
174 | All | 18 Years and older (Adult, Senior) | NCT00351728 | UCLA IRB #05-04-016 | June 2006 | August 2012 | August 2012 | July 13, 2006 | July 7, 2016 |
|
|||||
13 | NCT00109005 | Completed Has Results |
Lenalidomide (Revlimid) to Treat Advanced Ocular Melanoma |
|
|
Interventional | Phase 2 |
|
NIH |
|
|
17 | All | 18 Years and older (Adult, Senior) | NCT00109005 | 050095 05-C-0095 |
April 2005 | April 2009 | April 2009 | April 22, 2005 | January 2, 2017 | October 30, 2012 |
|
|
14 | NCT00062933 | Completed | A Phase II Study of Isolated Hepatic Perfusion (IHP) in Patients With Ocular Melanoma |
|
|
Interventional | Phase 2 |
|
NIH |
|
40 | All | 18 Years and older (Adult, Senior) | NCT00062933 | 030221 03-C-0221 |
June 2003 | September 2007 | March 2008 | June 18, 2003 | August 20, 2012 |
|
|||
15 | NCT02678572 | Recruiting | Percutaneous Hepatic Perfusion vs Best Alternative Care in Patients With Hepatic-dominant Ocular Melanoma |
|
|
Interventional | Phase 3 |
|
Industry / Other |
|
|
240 | All | 18 Years to 90 Years (Adult, Senior) | NCT02678572 | PHP-OCM-301 | FOCUS | January 2015 | June 2019 | June 2019 | February 10, 2016 | January 31, 2018 |
|
|
16 | NCT00421317 | Terminated | Imatinib in Adult Patients With Metastatic Ocular Melanoma |
|
|
Interventional | Phase 2 |
|
Other / Industry |
|
|
13 | All | 18 Years and older (Adult, Senior) | NCT00421317 | O-Mel-Inib 0508 | O-Mel-Inib | December 2005 | March 2007 | March 2007 | January 11, 2007 | January 6, 2016 |
|
|
17 | NCT00489944 | Unknown † | Sunitinib, Tamoxifen, and Cisplatin in Treating Patients With High-Risk Ocular Melanoma |
|
|
Interventional | Phase 2 |
|
Other |
|
|
50 | All | 18 Years and older (Adult, Senior) | NCT00489944 | CDR0000551559 POHA-0604 |
May 2007 | December 2012 | June 21, 2007 | January 10, 2014 |
|
|||
18 | NCT00085306 | Completed | Interferon Beta in Treating Patients With Metastatic Cutaneous Melanoma or Ocular Melanoma |
|
|
Interventional | Phase 2 |
|
Other / NIH |
|
|
21 | All | 18 Years and older (Adult, Senior) | NCT00085306 | CASE1604 P30CA043703 CCF-4049 |
April 2004 | October 2007 | October 2007 | June 11, 2004 | October 2, 2015 |
|
||
19 | NCT01587352 | Suspended | Vorinostat in Treating Patients With Metastatic Melanoma of the Eye |
|
|
Interventional | Phase 2 |
|
NIH / Other |
|
|
40 | All | 18 Years and older (Adult, Senior) | NCT01587352 | NCI-2012-00860 CUMC-IRBAAAO5917 AAAO5917 MSKCC-12-027 9111 N01CM00100 N01CM62206 P30CA013696 U01CA069856 UM1CA186689 |
April 20, 2012 | November 20, 2017 | April 30, 2012 | November 21, 2017 |
|
|||
20 | NCT01835145 | Completed | Cabozantinib-S-Malate Compared With Temozolomide or Dacarbazine in Treating Patients With Metastatic Melanoma of the Eye That Cannot Be Removed by Surgery |
|
|
Interventional | Phase 2 |
|
NIH / Other |
|
|
47 | All | 18 Years and older (Adult, Senior) | NCT01835145 | NCI-2013-00821 CALGB-A091201 A091201 U10CA180821 U10CA031946 |
July 31, 2013 | October 21, 2016 | October 21, 2016 | April 18, 2013 | February 28, 2018 |
|
||
21 | NCT00020475 | Completed | Vaccine Therapy in Treating Patients With Metastatic Melanoma of the Eye |
|
|
Interventional | Phase 2 |
|
NIH |
|
16 Years and older (Child, Adult, Senior) | NCT00020475 | CDR0000068514 NCI-01-C-0074 NCI-2910 |
February 2001 | March 2007 | March 6, 2007 | August 16, 2013 |
|
||||||
22 | NCT00003802 | Completed | Pyrazoloacridine in Treating Patients With Metastatic Skin or Eye Melanoma |
|
|
Interventional | Phase 2 |
|
Other / NIH |
|
All | 18 Years and older (Adult, Senior) | NCT00003802 | JHOC-J9875, CDR0000066946 U01CA063437 P30CA006973 JHOC-98111005 JHOC-JH9875 JHOC-T96-0116 NCI-T96-0116 |
February 1999 | October 2002 | May 2, 2003 | December 17, 2012 |
|
|||||
23 | NCT00482911 | Terminated Has Results |
Lenalidomide, Sunitinib, and Cyclophosphamide in Treating Patients With Stage IV Eye Melanoma |
|
|
Interventional | Phase 2 |
|
NIH |
|
|
12 | All | 18 Years and older (Adult, Senior) | NCT00482911 | 070134 NCI-07-C-0134 |
April 2007 | April 2009 | April 2009 | June 5, 2007 | March 27, 2017 | November 14, 2012 |
|
|
24 | NCT00036816 | Terminated | Vaccine Therapy in Treating Patients With Melanoma of the Eye |
|
|
Interventional | Phase 3 |
|
Other |
|
13 | All | 18 Years and older (Adult, Senior) | NCT00036816 | EORTC-18001 -88001 EORTC-18001 EORTC-88001 |
February 2002 | February 2003 | January 27, 2003 | September 24, 2012 |
|
||||
25 | NCT00000124 | Unknown † | Collaborative Ocular Melanoma Study (COMS) |
|
|
Interventional | Phase 3 |
|
NIH |
|
All | 21 Years and older (Adult, Senior) | NCT00000124 | NEI-23 | November 1986 | September 24, 1999 | June 2, 2006 | |||||||
26 | NCT03052127 | Recruiting | Phase 1B/2 Study in Subjects With Small to Medium Primary Choroidal Melanoma |
|
|
Interventional | Phase 1 Phase 2 |
|
Industry |
|
|
45 | All | 18 Years and older (Adult, Senior) | NCT03052127 | AU-011-101 | February 27, 2017 | March 2020 | March 2020 | February 14, 2017 | March 23, 2018 |
|
||
27 | NCT01728051 | No longer available | Expanded Access Study of Melphalan With Delcath CS-PHP System in Patients With Ocular/Cutaneous Melanoma Mets to Liver |
|
|
Expanded Access |
|
Industry | All | 18 Years and older (Adult, Senior) | NCT01728051 | MEL 2009-01 | November 16, 2012 | October 23, 2013 |
|
|||||||||
28 | NCT01143402 | Completed Has Results |
Temozolomide or Selumetinib in Treating Patients With Metastatic Melanoma of the Eye |
|
|
Interventional | Phase 2 |
|
NIH |
|
|
120 | All | 18 Years and older (Adult, Senior) | NCT01143402 | NCI-2011-01411 CDR0000674866 10-053 8443 N01CM00070 N01CM00071 N01CM00099 N01CM00100 N01CM62206 N01CM62208 P30CA008748 U01CA132123 |
June 2010 | May 2016 | May 2016 | June 14, 2010 | July 26, 2017 | May 18, 2017 |
|
|
29 | NCT00244816 | Completed | Taxoprexin® Treatment for Advanced Eye Melanoma |
|
|
Interventional | Phase 2 |
|
Industry |
|
|
30 | All | 13 Years and older (Child, Adult, Senior) | NCT00244816 | P01-04-22 | October 2005 | April 2007 | October 27, 2005 | January 24, 2018 |
|
|||
30 | NCT02697630 | Recruiting | Efficacy Study of Pembrolizumab With Entinostat to Treat Metastatic Melanoma of the Eye |
|
|
Interventional | Phase 2 |
|
Other / Industry |
|
|
29 | All | 18 Years and older (Adult, Senior) | NCT02697630 | 2016-1 | PEMDAC | February 21, 2018 | August 2021 | August 2023 | March 3, 2016 | February 23, 2018 |
|
|
31 | NCT01413191 | Completed Has Results |
Cixutumumab in Treating Patients With Metastatic Melanoma of the Eye |
|
|
Interventional | Phase 2 |
|
NIH |
|
|
18 | All | 17 Years and older (Child, Adult, Senior) | NCT01413191 | NCI-2011-02228 2010-0451 8832 P30CA016672 N01CM00039 |
August 2011 | March 2013 | June 2014 | August 10, 2011 | July 20, 2015 | July 20, 2015 |
|
|
32 | NCT00406120 | Withdrawn | Validation of a Molecular Prognostic Test for Eye Melanoma |
|
|
Observational |
|
Other |
|
2000 | All | Child, Adult, Senior | NCT00406120 | 98-0042-A | January 2007 | December 2017 | December 4, 2006 | May 17, 2007 |
|
|||||
33 | NCT01217398 | Unknown † | Temozolomide and Bevacizumab in Treating Patients With Metastatic Melanoma of the Eye |
|
|
Interventional | Phase 2 |
|
Other |
|
|
35 | All | 18 Years and older (Adult, Senior) | NCT01217398 | CDR0000683852 CLCC-IC-2009-01 EUDRACT-2009-011751-46 EU-21063 |
October 2009 | October 2012 | October 8, 2010 | August 26, 2013 |
|
|||
34 | NCT00952939 | Completed | Study of Tumor Samples in Patients Undergoing Radiation Therapy or Surgery For Primary Melanoma of the Eye |
|
|
Observational |
|
Other / NIH |
|
|
150 | All | 18 Years and older (Adult, Senior) | NCT00952939 | CASE5608 P30CA043703 CASE 5608-CC666 |
March 2009 | September 2012 | February 2014 | August 6, 2009 | January 30, 2015 |
|
|||
35 | NCT00329641 | Completed Has Results |
Sorafenib, Carboplatin, and Paclitaxel in Treating Patients With Stage IV Melanoma of the Eye |
|
|
Interventional | Phase 2 |
|
NIH |
|
|
25 | All | 18 Years and older (Adult, Senior) | NCT00329641 | NCI-2009-00777 CDR0000467188 S0512 U10CA032102 |
February 2011 | November 2012 | November 2012 | May 25, 2006 | July 31, 2014 | July 11, 2012 |
|
|
36 | NCT00738361 | Completed Has Results |
Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Metastatic Melanoma of the Eye That Cannot Be Removed By Surgery |
|
|
Interventional | Phase 2 |
|
Other / Industry |
|
|
4 | All | 18 Years and older (Adult, Senior) | NCT00738361 | OSU-08076 NCI-2011-03176 |
August 2008 | July 2012 | April 2013 | August 20, 2008 | February 12, 2016 | February 12, 2016 |
|
|
37 | NCT00110123 | Terminated | Intravenous or Hepatic Arterial Infusion of Fotemustine in Treating Patients With Unresectable Liver Metastases From Eye Melanoma |
|
|
Interventional | Phase 3 |
|
Other |
|
|
171 | All | 18 Years and older (Adult, Senior) | NCT00110123 | EORTC-18021 2004-002245-12 |
January 2005 | June 2011 | May 4, 2005 | September 24, 2012 |
|
|||
38 | NCT02858869 | Recruiting | Pembrolizumab and Stereotactic Radiosurgery for Melanoma or Non-Small Cell Lung Cancer Brain Metastases |
|
|
Interventional | Phase 1 |
|
Other / Industry |
|
|
30 | All | 18 Years and older (Adult, Senior) | NCT02858869 | IRB00086461 NCI-2016-00718 RAD3179-16 |
October 4, 2016 | October 2019 | October 2020 | August 8, 2016 | January 16, 2018 |
|
||
39 | NCT02129075 | Suspended | CDX-1401 and Poly-ICLC Vaccine Therapy With or Without CDX-301 in Treating Patients With Stage IIB-IV Melanoma |
|
|
Interventional | Phase 2 |
|
NIH |
|
|
100 | All | 18 Years and older (Adult, Senior) | NCT02129075 | NCI-2014-00898 s14-01284 CITN-07-FLT3L P30CA015704 U01CA154967 |
April 9, 2014 | February 2, 2020 | May 2, 2014 | March 13, 2018 |
|
|||
40 | NCT02376920 | Active, not recruiting | 5 Year Registry Study to Track Clinical Application of DecisionDx-UM Assay Results and Associated Patient Outcomes |
|
Observational |
|
Industry |
|
|
2800 | All | 16 Years and older (Child, Adult, Senior) | NCT02376920 | 2-01 | CLEAR | March 2010 | October 2020 | October 2020 | March 3, 2015 | January 25, 2018 | ||||
41 | NCT01801358 | Terminated Has Results |
A Phase Ib/II Study of AEB071 and MEK162 in Adult Patients With Metastatic Uveal Melanoma |
|
|
Interventional | Phase 1 Phase 2 |
|
Industry |
|
|
38 | All | 18 Years and older (Adult, Senior) | NCT01801358 | CMEK162X2203 | August 2013 | May 2015 | May 2015 | February 28, 2013 | October 20, 2016 | October 20, 2016 |
|
|
42 | NCT02315066 | Recruiting | Study Of OX40 Agonist PF-04518600 Alone And In Combination With 4-1BB Agonist PF-05082566 |
|
|
Interventional | Phase 1 |
|
Industry |
|
|
210 | All | 18 Years and older (Adult, Senior) | NCT02315066 | B0601002 2014-004107-75 |
April 2015 | December 2018 | August 2020 | December 11, 2014 | March 8, 2018 |
|
||
43 | NCT01473004 | Active, not recruiting | SIR-Spheres® 90Y Microspheres Treatment of Uveal Melanoma Metastasized to Liver |
|
|
Interventional | Phase 2 |
|
Other |
|
|
48 | All | 18 Years and older (Adult, Senior) | NCT01473004 | 10D.95 | October 31, 2011 | January 1, 2019 | January 1, 2020 | November 17, 2011 | November 13, 2017 |
|
||
44 | NCT01046487 | Completed | Imatinib Mesylate And Cyclophosphamide In Metronomic Administration: Dose Escalation Study Of Imatinib Mesylate |
|
|
Interventional | Phase 1 |
|
Other |
|
|
26 | All | 18 Years and older (Adult, Senior) | NCT01046487 | PALANGI-3 0804 | PALANGI3 | January 2009 | April 2011 | February 2012 | January 12, 2010 | June 7, 2012 |
|
† Study has passed its completion date and status has not been verified in more than two years.